Skip to main content

Table 1  Patient characteristics of the 218 patients in medullary thyroid carcinoma (MTC) with lateral cervical lymph node metastases (LCLNM) negative (N0/N1a) and positive (N1b)

From: Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer

Characteristics

LCLNM negative (n=111)

LCLNM positive (n=107)

p-Value

Age (years)a

49 (13~78)

50 (21~75)

0.995

Sexb

  

<0.001

 Male

39 (35.1)

63 (58.9)

 

 Female

72 (64.9)

44 (41.1)

 

ACR TI-RADS

   

 Compositionb

  

0.222

  Cystic or Spongiform

0 (0.0)

0 (0.0)

 

  Mixed cystic and nodule

11 (9.9)

5 (4.7)

 

  Solid

100 (90.1)

102 (95.3)

 

 Echogenicityb

  

0.491

  Anechoic

0 (0.0)

0 (0.0)

 

  Hyperechoic or isoechoic

3 (2.7)

2 (1.9)

 

  Hypoechoic

89 (80.2)

80 (74.8)

 

  Very hypoechoic

19 (17.1)

25 (23.4)

 

 Shapeb

  

0.392

  Wider-than-tall

105 (94.6)

97 (90.7)

 

  Taller-than-wide

6 (5.4)

10 (9.3)

 

 Marginb

  

<0.001

  Smooth or Ill-defined

22 (19.8)

7 (6.5)

 

  Lobulated or Irregular

87 (78.4)

69 (64.5)

 

  Extra-thyroidal extension

2 (1.8)

31 (29.0)

 

 Echogenic Focib

  

0.393

  None or Large comet-tail artifacts

49 (44.1)

38 (35.5)

 

  Macrocalcifications

41 (36.9)

48 (44.9)

 

  Peripheral(rim) calcifications

0 (0.0)

0 (0.0)

 

  Punctate echogenic foci

21 (18.9)

21 (19.6)

 

 TI-RADS Levelb

  

0.016

  TR1

0 (0.0)

0 (0.0)

 

  TR2

1 (0.9)

0 (0.0)

 

  TR3

5 (4.6)

0 (0.0)

 

  TR4

35 (31.5)

22 (20.6)

 

  TR5

70 (63.1)

85 (79.4)

 
  1. aData are presented as medians with ranges in parentheses
  2. bData in parentheses are percentages